U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
FORM 4
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
Donohoe, Michael J.
Allergan, Inc.
2525 Dupont Drive
Irvine, CA 92612
U.S.A.
2. Issuer Name and Ticker or Trading Symbol
Allergan, Inc.
AGN
3. IRS or Social Security Number of Reporting Person (Voluntary)
4. Statement for Month/Year
August, 1996
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person to Issuer (Check all applicable)
( ) Director ( ) 10% Owner (X) Officer (give title below) ( ) Other
(specify below)
Corporate Vice President and President, Europe Region
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1. Title of Security |2. |3. |4.Securities Acquired (A) |5.Amount of |6.Dir |7.Nature of Indirect |
| Transaction | or Disposed of (D) | Securities |ect | Beneficial Ownership |
| | | | Beneficially |(D)or | |
| | | | | A/| | Owned at |Indir | |
| Date |Code|V| Amount | D | Price | End of Year |ect(I)| |
___________________________________________________________________________________________________________________________________|
<S> <C> <C> <C><C> <C> <C> <C> <C> <C>
Common Stock |(1) |J (|V|37 |A |(1) |129 |I |By Trust (2) |
| |1) | | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock | | | | | | |5,890 |I |By Trust (3) |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock | | | | | | |100 |I |By Trust (4) |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |(5) |J (5|V|6 |A |(5) |1,038 |I |By ESOP Trust |
| |) | | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock |(6) |J (6|V|74 |A |(6) |1,484 |I |By 401(k) Trust |
| |) | | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con- |3. |4. |5.Number of De |6.Date Exer|7.Title and Amount |8.Price|9.Number |10.|11.Nature of|
Security |version |Transaction | rivative Secu |cisable and| of Underlying |of Deri|of Deriva |Dir|Indirect |
|or Exer | | | rities Acqui |Expiration | Securities |vative |tive |ect|Beneficial |
|cise | | | red(A) or Dis |Date(Month/| |Secu |Securities |(D)|Ownership |
|Price of| | | posed of(D) |Day/Year) | |rity |Benefi |or | |
|Deriva- | | | |Date |Expir| | |ficially |Ind| |
|tive | | | | A/|Exer-|ation| Title and Number | |Owned at |ire| |
|Secu- | | | | | D |cisa-|Date | of Shares | |End of |ct | |
|rity |Date |Code|V| Amount | |ble | | | |Year |(I)| |
___________________________________________________________________________________________________________________________________|
<S> <C> <C> <C> <C><C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Employee Stock Option |$35.125 |4/22/|A (7|V|26,400 |A |(7) |4/22/|Common Stock|26,400 | |161,559 |D | |
(right to buy) with ta| |96 |) | | | | |06 | | | | | | |
ndem tax withholding r| | | | | | | | | | | | | | |
ight | | | | | | | | | | | | | | |
- -----------------------------------------------------------------------------------------------------------------------------------|
| | | | | | | | | | | | | | |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1) Shares were acquired from 3/11/96 through 6/17/96 under the Charles Schwab
and Co., Inc. dividend reinvestment plan in transactions exempt
from Section 16(b) by virtue of Rule 16a-11 at prices ranging from $36.625 to
$40.875 per share. Information presented is as of 8/14/96.
(2) Revocable family trust established by reporting person as co-settlor for
benefit of self and others, representing a change in form of ownership,
exempt from Section 16(b) under Rule
16a-13.
(3) Transfer of shares into a revocable family trust established by reporting
person as co-settlor for benefit of self and others, representing a
change in form of ownership, exempt from Section 16(b) under Rule
16a-13.
(4) Reporting person is co-trustee and has a pecuniary interest under the
rules.
(5) The shares were purchased by the Allergan, Inc. Employee Stock Ownership
Plan at a price of $23.7812 per share. The information presented
is as of
8/14/96.
(6) Shares were acquired from 1/1/96 through 8/14/96 under the Allergan, Inc.
Savings and Investment Plan at prices ranging from $31.25 to $41.75
per share, in transactions exempt from Section 16(b) by virtue of Rule
16b-3(c). The information presented is as of 8/14/96.
(7) Granted pursuant to the Allergan, Inc. 1989 Incentive Compensation Plan,
which complies with Rule 16b-3(d); the option becomes exercisable in
25% increments on 4/22/97, 4/22/98, 4/22/99 and
4/22/00.
SIGNATURE OF REPORTING PERSON
/s/ Michael J. Donohoe
DATE
9/19/96
